Rezolute Inc (RZLT)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $353.54M
Last updated: Nov 17, 2026 at 11:06 AM ET
Rezolute Inc (RZLT) Stock Forecast
Analysts expect Rezolute (RZLT) to earn -$0.67 per share in the fiscal year ending Jun 30, 2027, on revenue of $2.09M. Of 11 analysts, 11 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Jun 30, 2027 was revised up and 6 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 11 ratings average 1.82, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 2 | 18.2% |
| Buy | 9 | 81.8% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 11
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 2541.1%.
- Fiscal year ending Jun 30, 2027
- -$0.67
- EPS consensus, revenue $2.09M
- Fiscal year ending Jun 30, 2028
- -$0.44
- EPS consensus, revenue $55.20M
- Next report
- Feb 10, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Jun 30, 2027 | -$0.67 | -$0.74 to -$0.60 | 8 | $2.09M | N/A | 11 |
| Jun 30, 2028 | -$0.44 | -$0.80 to -$0.15 | 8 | $55.20M | $3.86M to $186.25M | 11 |
Quarterly Estimates
Across the 3 quarters below, the EPS consensus is lowest for the quarter ending Jun 30, 2027, at -$0.18, and highest for the quarter ending Dec 31, 2026, at -$0.17.
EPS range
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$0.17 | -$0.19 to -$0.14 | 8 |
| Mar 31, 2027 | -$0.17 | -$0.20 to -$0.13 | 8 |
| Jun 30, 2027 | -$0.18 | -$0.22 to -$0.13 | 13 |
Estimate Revisions
Across the 4 periods below, the last 30 days brought 2 upward and 16 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Jun 30, 2027 | 1 | 6 |
| Fiscal year ending Jun 30, 2028 | 1 | 3 |
| Quarter ending Dec 31, 2026 | 0 | 4 |
| Quarter ending Mar 31, 2027 | 0 | 3 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Jun 30, 2027 has worsened from -$0.63.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Jun 30, 2027 | -$0.67 | -$0.70 | -$0.70 | -$0.63 | -$0.63 | N/A |
| Fiscal year ending Jun 30, 2028 | -$0.44 | -$0.47 | -$0.47 | -$0.28 | -$0.28 | N/A |
| Quarter ending Dec 31, 2026 | -$0.17 | -$0.17 | -$0.17 | -$0.13 | -$0.13 | N/A |
| Quarter ending Mar 31, 2027 | -$0.17 | -$0.18 | -$0.18 | -$0.14 | -$0.14 | N/A |
Frequently Asked Questions About RZLT
What is the RZLT stock forecast?
Consensus analyst estimates put Rezolute's EPS at -$0.67 for the fiscal year ending Jun 30, 2027, on revenue of $2.09M. The consensus rating from 11 analysts is Buy.
How do analysts rate RZLT stock?
Of 11 analysts covering Rezolute, 2 rate it Strong Buy, 9 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from RZLT next year?
For the fiscal year ending Jun 30, 2027, the consensus EPS estimate is -$0.67, with estimates from -$0.74 to -$0.60 from 8 analysts. For the fiscal year ending Jun 30, 2028, the consensus EPS estimate is -$0.44, with estimates from -$0.80 to -$0.15 from 8 analysts.
What revenue do analysts expect from Rezolute next year?
For the fiscal year ending Jun 30, 2027, the consensus revenue estimate is $2.09M. For the fiscal year ending Jun 30, 2028, the consensus revenue estimate is $55.20M, with estimates from $3.86M to $186.25M.
How many analysts cover RZLT?
11 analysts rate Rezolute stock, and 8 analysts estimate its EPS for the fiscal year ending Jun 30, 2027.
RZLT pages: Overview, Earnings, Forecast, Financials, Competitors